Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Roche Holding
AddedFeb 13, 2024
UpdatedJun 28, 2026
Roche Holding

Roche Holding

Public

Roche Holding AG, a Swiss healthcare company, globally manufactures and develops pharmaceutical and diagnostic products.

HQ
Basel, Basel-Stadt, CH
Founded
1896
Overview
Compare
Fundraising
Employees
News
Website

Founded on October 1, 1896, by Fritz Hoffmann-La Roche, Roche Holding AG is a Swiss healthcare company headquartered in Basel. The company's core mission is to innovate healthcare solutions that meet the evolving needs of patients worldwide. Roche develops and manufactures pharmaceutical and diagnostic products, focusing on areas such as cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system. The company serves a global market, providing essential medical products and services to healthcare providers and patients.

Notable figures associated with Roche include Severin Schwan, the Chairman, and André Hoffmann, the Vice-Chairman. Over its long history, Roche has achieved significant milestones, including pioneering advancements in personalized medicine and diagnostics. The company is publicly traded on the SIX Swiss Exchange under the symbols RO (voting) and ROG (non-voting). Roche's impact is profound, continually driving forward innovations that improve patient outcomes and setting high standards in the pharmaceutical and diagnostics industries.

Roche Holding - Products & Services

  • Faricimab logo

    Faricimab

    Faricimab is a bispecific antibody targeting VEGF and angiopoietin-2 for retinal vascular diseases.

    Competing Products

    Memento Medicines logo

Roche Holding - Similar Companies

Memento Medicines logo

Memento Medicines

Lonza logo

Lonza

Bayer logo

Bayer

bayer.com

Ferring logo

Ferring

ferring.com

Boehringer Ingelheim logo

Boehringer Ingelheim

Genentech logo

Genentech

gene.com

Sanofi logo

Sanofi

sanofi.com

Regeneron Ph logo

Regeneron Ph

regeneron.com

Novartis Pharma logo

Novartis Pharma

Bayer Pharmaceuticals logo

Bayer Pharmaceuticals

bayer.com

Novartis logo

Novartis

novartis.com

Merck & CO INC Cedear EAC 5 RE logo

Merck & CO INC Cedear EAC 5 RE

merck.com

AstraZeneca logo

AstraZeneca

astrazeneca.com

Vifor Pharma logo

Vifor Pharma

viforpharma.com

AbbVie logo

AbbVie

abbvie.com

Roche Holding - Quick Facts

Who are Roche Holding's competitors?

Companies similar to Roche Holding include Memento Medicines, Lonza, Bayer and Ferring.

When was Roche Holding founded?

Roche Holding was founded in 1896.

Where is Roche Holding's headquarters located?

Roche Holding's headquarters is located in Basel, Basel-Stadt, CH.

When was Roche Holding's last funding round?

Roche Holding's most recent funding round was for $5B (USD) in August 2021.

How much has Roche Holding raised to-date?

As of Aug 4, 2021, Roche Holding has raised a total of $7.8B (USD).

How many employees does Roche Holding have?

Roche Holding has 103,613 employees as of Feb 6, 2024.

Roche Holding - Classification

Industry
  • Retail
Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Transactional
Customer
  • Consumers
  • Enterprise
Tags
  • Distribution
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
Show 15 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 623000Nursing and Residential Care Facilities
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8800Private households
  • 6000Depository Institutions
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research